Tom Frohlich
2020
In 2020, Tom Frohlich earned a total compensation of $2.6M as Chief Business Officer at Aduro BioTech.
Compensation breakdown
| Non-Equity Incentive Plan | $117,529 |
|---|---|
| Option Awards | $1,537,975 |
| Salary | $307,413 |
| Stock Awards | $601,774 |
| Other | $1,488 |
| Total | $2,566,179 |
Frohlich received $1.5M in option awards, accounting for 60% of the total pay in 2020.
Frohlich also received $117.5K in non-equity incentive plan, $307.4K in salary, $601.8K in stock awards and $1.5K in other compensation.
Rankings
In 2020, Tom Frohlich's compensation ranked 4,442nd out of 13,090 executives tracked by ExecPay. In other words, Frohlich earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,442 out of 13,090 | 66th |
Division Manufacturing | 1,802 out of 5,621 | 68th |
Major group Chemicals And Allied Products | 700 out of 2,254 | 69th |
Industry group Drugs | 599 out of 1,954 | 69th |
Industry Pharmaceutical Preparations | 455 out of 1,459 | 69th |
Source: SEC filing on April 23, 2021.
Frohlich's colleagues
We found four more compensation records of executives who worked with Tom Frohlich at Aduro BioTech in 2020.